Overview

Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment

Status:
Not yet recruiting

Trial end date:
2023-05-31

Target enrollment:

Participant gender:

Summary

Pharmacological proof-of-concept study on the effects of 10 mg fampridine (twice daily oral administration during 3.5 days) on physiological processes, in particular working memory, in individuals with post COVID-19 condition. The hypothesis ist that fampridine improves working memory performance.

Phase:

N/A

Details

Lead Sponsor:

Prof. Dominique de Quervain, MD

Collaborators:

Clinical Trial Unit, University Hospital Basel, Switzerland
University Hospital, Basel, Switzerland

Treatments:

4-Aminopyridine